JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SCHR
5426
Schwab Intermediately-Term US Treasury ETF
SCHR
$13B
| $4K | ﹤0.01% |
+156
| New | +$4.14K |
2019 Q1
0 quarters
|
|
5427
abrdn Physical Silver Shares ETF
SIVR
$4.1B
| $4K | ﹤0.01% |
300
| – | – |
2015 Q4
13 quarters
|
|
5428
ProShares Ultra Materials
UYM
$34.2M
| $4K | ﹤0.01% |
292
| – | – |
2018 Q4
1 quarter
|
|
5429
VanEck Vietnam ETF
VNM
$483M
| $4K | ﹤0.01% |
269
| – | – |
2013 Q2
23 quarters
|
|
5430
X4 Pharmaceuticals
XFOR
$281M
| $4K | ﹤0.01% |
7
-3
| -30% | -$1.66K |
2017 Q4
5 quarters
|
|
5431
Zevra Therapeutics
ZVRA
$593M
| $4K | ﹤0.01% |
+134
| New | +$4.93K |
2019 Q1
0 quarters
|
|
|
PHLT
5432
DELISTED
Performant Healthcare Inc
PHLT
| $4K | ﹤0.01% |
2,000
+76
| +4% | +$159 |
2018 Q4
1 quarter
|
|
|
WHWK
5433
Whitehawk Therapeutics
WHWK
$211M
| $4K | ﹤0.01% |
+320
| New | +$13.8K |
2019 Q1
0 quarters
|
|
|
AUMN
5434
DELISTED
Golden Minerals Company
AUMN
| $4K | ﹤0.01% |
603
| – | – |
2013 Q2
23 quarters
|
|
|
IDEX
5435
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $4K | ﹤0.01% |
+18
| New | +$3.4K |
2019 Q1
0 quarters
|
|
|
KLDO
5436
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $4K | ﹤0.01% |
+300
| New | +$4.13K |
2019 Q1
0 quarters
|
|
|
ZOM
5437
DELISTED
Zomedica Corp.
ZOM
| $4K | ﹤0.01% |
10,532
-4,821
| -31% | -$4.25K |
2018 Q2
3 quarters
|
|
|
SCOM
5438
DELISTED
ProShares UltraPro Short Communication Services Select Sector
SCOM
| $4K | ﹤0.01% |
+107
| New | +$3.86K |
2019 Q1
0 quarters
|
|
|
SDT
5439
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
| $4K | ﹤0.01% |
+4,000
| New | +$3.98K |
2019 Q1
0 quarters
|
|
|
AREX
5440
DELISTED
Approach Resources Inc.
AREX
| $4K | ﹤0.01% |
10,990
-516
| -4% | -$484 |
2017 Q4
5 quarters
|
|
|
TST
5441
DELISTED
TheStreet, Inc.
TST
| $4K | ﹤0.01% |
+180
| New | +$3.94K |
2019 Q1
0 quarters
|
|
|
AKAO
5442
DELISTED
Achaogen Inc
AKAO
| $4K | ﹤0.01% |
8,019
| – | – |
2017 Q1
8 quarters
|
|
|
NAVB
5443
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $4K | ﹤0.01% |
1,300
| – | – |
2018 Q2
3 quarters
|
|
|
HAO
5444
DELISTED
Invesco China Small Cap ETF
HAO
| $4K | ﹤0.01% |
156
| – | – |
2018 Q4
1 quarter
|
|
5445
ProShares Ultra Silver
AGQ
$1.27B
| $3K | ﹤0.01% |
120
| – | – |
2018 Q4
1 quarter
|
|
5446
ProShares Ultra Bloomberg Natural Gas
BOIL
$272M
| – | – |
0
| – | – |
2019 Q1
0 quarters
|
|
|
STEX
5447
Streamex Corp
STEX
$71.3M
| $3K | ﹤0.01% |
+50
| New | +$2.54K |
2019 Q1
0 quarters
|
|
5448
Cardiff Oncology
CRDF
$87.1M
| $3K | ﹤0.01% |
846
-1
| -0.1% | -$4 |
2017 Q3
6 quarters
|
|
5449
Gevo
GEVO
$324M
| $3K | ﹤0.01% |
1,210
-1,801
| -60% | -$4.43K |
2018 Q1
4 quarters
|
|
5450
SPDR Gold MiniShares Trust
GLDM
$30.3B
| $3K | ﹤0.01% |
+99
| New | +$2.58K |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.